Menu

News

You can filter the posts based on tags:

Archives

All posts
Asthma & 

Allergy
Chronic Obstructive 

Pulmonary Disease
Cystic 

Fibrosis
Pneumonia and 

Acute Lung Injury
Diffuse Parenchymal 

Lung Disease
Pulmonary 

Hypertension
End-Stage 

Lung Disease
Lung Cancer
Biobanking, Data Management 

and Imaging Platform
Prices & 

Awards
5. August 2020
Assembly within the tumor center

Number of macrophages in tumor tissue enables prognosis of lung tumor progression.

Weiterlesen
18. July 2020
The dangerous dual role of the immune system in COVID-19

Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course. The immune system plays a decisive role.

Weiterlesen
17. July 2020
DZL-researcher elected as new EMBO Member

Ursula Klingmüller was recognised for her outstanding scientific achievements by being elected as a Member of the European Molecular Biology Organisation (EMBO).

Weiterlesen
10. June 2020
Drug Against COPD in Sight

Work group of DZL researcher identifies target molecule for the treatment of chronic obstructive pulmonary disease (COPD).

Weiterlesen
9. June 2020
Re-education of tumor-associated macrophages offers novel immunotherapeutic option for lung cancer

Lung cancer is the leading cause of cancer death for both men and women and accounts for almost 28% of all cancer deaths worldwide.

Weiterlesen
24. April 2020
What Is the Impact of E-Cigarettes on the Lungs?

In a new project, scientists at the German Center for Lung Research (DZL) investigate the impact of e-cigarette vapor on lung health. This interdisciplinary approach combines various projects of all five sites.

Weiterlesen
15. April 2020
Helpers on the wrong path: Lymphocytes can force lung cancer

T-helper cells stimulate the building of lung cancer metastasis.

Weiterlesen
9. April 2020
The DZIF and DZL Coordinate the WHO Solidarity Trial in Germany

A top global priority is to find agents that can stop the severe course of COVID-19 infection and consequently increase the chances of patient survival as rapidly as possible.

Weiterlesen
7. April 2020
What cells does the novel Coronavirus attack?

Scientists from the Berlin Institute of Health (BIH), Charité and the Thorax Clinic at Heidelberg University Hospital, whose collaboration is taking place under the auspices of the German Center for Lung Research (DZL), have examined samples from non-virus infected patients to determine which cells of the lungs and bronchi are targets for novel coronavirus (SARS-CoV-2) infection.

Weiterlesen
27. March 2020
CAPNETZ Extends Clinical Trial to Coronavirus Patients

Founded in 2001, the CAPNETZ research network is an associated partner of the DZL and has recorded clinical data from over 13,000 patients with community-acquired pneumonia (CAP) so far.

Weiterlesen
18. March 2020
EU promotes lung research at the Max Planck Institute in Bad Nauheim

Soni Savai Pullamsetti Receives 2 Million Euro Research Grant from the European Research Council.

Weiterlesen
7. January 2020
9th DZL Annual Meeting with Many Highlights

The 9th DZL Annual Meeting took place on January 23 and 24, 2020 in Lübeck-Travemünde, bringing together around 500 scientists, physicians, and junior researchers from five sites.

Weiterlesen
1 2 3 9
5. August 2019
Correlation Found Between miRNAs and Asthma Development

MicroRNAs, also called miRNAs or miR, play an important role in cell communication and affect gene activity in various ways.

Weiterlesen
21. March 2019
The Lung Microbiome – the latest ERS Monograph

Studying the lung microbiome requires a specialist approach to sampling, laboratory techniques and statistical analysis.

Weiterlesen
20. February 2014
DZL PhD student Lars Lunding honored twice at DGP Annual Congress

DZL PhD student Lars Lunding received two awards at the 55th Annual Congress of the German Respiratory Society.

Weiterlesen
27. February 2013
DZL Researchers Find New Therapeutic Target for Asthma

DZL researchers have found that polymorphisms in a chloride channel gene are associated with asthma, pointing the way towards new therpeutic options.

Weiterlesen
10. June 2020
Drug Against COPD in Sight

Work group of DZL researcher identifies target molecule for the treatment of chronic obstructive pulmonary disease (COPD).

Weiterlesen
21. March 2019
The Lung Microbiome – the latest ERS Monograph

Studying the lung microbiome requires a specialist approach to sampling, laboratory techniques and statistical analysis.

Weiterlesen
7. January 2019
COPD and Its Comorbidities: New Evidence Gained from the COSYCONET Cohort Study

The cohort study COSYCONET investigates how lung health, comorbidities, and systemic inflammation are related in patients with Chronic Obstructive Pulmonary Disease (COPD).

Weiterlesen
3. May 2018
COPD associated inflammation halted in model experiment

Scientists at Helmholtz Zentrum München, member of the DZL, have now reported a previously unknown pathogenic mechanism..

Weiterlesen
3. July 2017
How does pathological iron overload affect the lung?

Scientists from the German Center for Lung Research (DZL) developed an animal model of severe iron overload to investigate the mechanisms of pulmonary iron deposition and their effects on lung function.

Weiterlesen
2. March 2017
Cigarette smoke curbs lung's self-healing

Smoke from cigarettes blocks self-healing processes in the lungs and consequently can lead to chronic obstructive pulmonary disease (COPD)…

Weiterlesen
16. December 2016
COPD – what causes the lungs to lose their ability to heal?

Scientists at the Helmholtz Zentrum München found...

Weiterlesen
3. June 2019
New Gene-Delivery Systems Raise Hope for Patients with Cystic Fibrosis

Although research is advancing with great strides, the life expectancy of people with cystic fibrosis (CF) is still significantly reduced.

Weiterlesen
21. March 2019
Research Prizes for DZL Scientists at the 60th DGP Congress in Munich

The DZL was represented with an information desk at the 60th Congress of the German Respiratory Society (DGP), which took place in Munich from March 13–16, 2019.

Weiterlesen
6. October 2017
Cystic Fibrosis: prevention of chronic lung infections

Chronic infections with the pathogen Pseudomonas aeruginosa change the lung microbiome in CF-patients.

Weiterlesen
19. June 2017
Adolf-Windorfer prize awarded to DZL working group

Cystic Fibrosis: Junior Scientist Dr. Patricia Morán Losada...

Weiterlesen
28. November 2016
Non-invasive and radiation-free early diagnosis and therapeutic monitoring of patients with cystic fibrosis lung disease

Results recently published confirm the sensitivity of magnetic resonance imaging (MRI) and the lung clearance index (LCI),  a measure of abnormal ventilation distribution...

Weiterlesen
24. November 2014
DZL PI Dr. Mark Oliver Wielpütz Receives Christiane Herzog Research Award 2014

TLRC Researcher receives Christiane Herzog Research Award 2014.

Weiterlesen
12. May 2014
ERS Monograph on Cystic Fibrosis

DZL Director Marcus Mall and DZL Scientific Advisory Board member Stuart Elborn co-edited the European Respiratory Monograph on Cystic Fibrosis (CF)

Weiterlesen
16. April 2014
New Method for Detecting Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis

DZLresearchers from the TLRC site publish breakthrough method for non-invasive early diagnosis of pulmonary changes in infants and young children with cystic fibrosis

Weiterlesen
25. June 2013
Adolf-Windorfer Prize Awarded to DZL PI Dr. Frauke Stanke

DZL Faculty Member, Dr. Frauke Stanke is awarded the 2013 Adolf-Windorfer Prize for groundbreaking work in the field of Cystic Fibrosis.

Weiterlesen
20. January 2017
Nanoparticle exposure can awaken dormant viruses in the lungs

Nanoparticles from combustion engines can activate viruses that are dormant in in lung tissue cells. This is the result of a study by researchers of Helmholtz Zentrum München, a partner in the German Center for Lung Research (DZL), which has now been published in the journal ‘Particle and Fibre Toxicology’.

Weiterlesen
9. May 2019
Targeted Detection of Chronic Lung Disease in Premature Infants

Prematurely born infants often develop a chronic lung disease known as Bronchopulmonary Dysplasia (BPD). To date, it has only been possible to diagnose the condition based on clinical symptoms and with little differentiation.

Weiterlesen
20. December 2017
Idiopathic pulmonary fibrosis caused by single transcription factor

DZL Scientists showed that reduced FoxO3 activity reprograms connective tissue cells, triggering the disease...

Weiterlesen
29. September 2017
How the lungs of premature babies can undergo damage

Premature babies that need ventilation to support their breathing often suffer from a condition known as bronchopulmonary dysplasia. Researchers of the DZL Sites Munich and Giessen and further institutions have now discovered a molecular mechanism that plays a key role in the development of the disease. The study has been published in ‘EMBO Molecular Medicine’.

Weiterlesen
4. August 2017
Cell aging in lung epithelial cells

Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the DZL sites Munich and Giessen. As they report in the ‘European Respiratory Journal’, they have already successfully counteracted this mechanism in the cell culture with the help of drugs.

Weiterlesen
14. July 2017
Is idiopathic pulmonary fibrosis due to an autoimmune disorder?

A new study under the lead of DZL scientists has shown, autoimmune reactions may be a causal factor in more patients as currently expected. The results have been published in the ‘American Journal of Respiratory and Critical Care Medicine’.

Weiterlesen
17. October 2014
DZL Neonatology Symposium held in Giessen

More than 150 participants attend DZL Neonatology Symposium in Giessen.

Weiterlesen
27. May 2014
DZL- Initiated ILD Registry "EXCITING" Goes Live

The new DZL- initiated registry for “Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases” (in short “EXCITING”) is now recruiting.

Weiterlesen
3. February 2014
Two DZL Researchers Share the 2013 Oskar Medicine Prize

The 2013 Oskar Medicine Prize was awarded to two DZL researchers from the UGMLC site, Prof. Dr. Andreas Günther and Prof. Dr. Philipp Markart.  They shared prize for their pioneering work on interstitial lung diseases.

Weiterlesen
26. April 2019
Dr. Astrid Weiß and Moritz Neubauer Honored with René Baumgart Award

Pulmonary Arterial Hypertension (PAH) is a progressive, fatal disease of the pulmonary vasculature. Affected patients have a poor prognosis, and treatment options are limited.

Weiterlesen
21. March 2019
Research Prizes for DZL Scientists at the 60th DGP Congress in Munich

The DZL was represented with an information desk at the 60th Congress of the German Respiratory Society (DGP), which took place in Munich from March 13–16, 2019.

Weiterlesen
14. January 2019
Brown Seaweed Extract as a New Therapeutic Approach to Pulmonary Hypertension

Pulmonary Hypertension (PH) is a severe condition of the lungs and the heart, which cannot be cured.

Weiterlesen
17. November 2017
How lung cancer triggers pulmonary hypertension

Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension – DZL scientists of…

Weiterlesen
27. March 2017
DZL Scientist Prof. Dr. Marius Hoeper receives Oskar Medicine Award

...for his game-changing research in the area of Pulmonary Hypertension...

Weiterlesen
19. November 2014
2014 Dickinson W. Richards Memorial Lecture given by DZL Speaker Werner Seeger

Prof. Dr. Werner Seeger gave the 2014 Dickinson W. Richards Memorial Lecture at the American Heart Association Meeting in Chicago.

Weiterlesen
29. October 2014
New Therapeutic Approach for Pulmonary Hypertension

DZL UGMLC researchers discover a new therapeutic approach for treating pulmonary hypertension.

Weiterlesen
26. June 2014
DZL PI Prof. Dr. Axel Haverich Receives Fritz Behrens Prize

DZL PI Prof. Dr. Axel Haverich was honored with the renowned Fritz Behrens Prize for his life’s work on June 17th in Hannover.

Weiterlesen
20. September 2012
First Living Donor Lung Transplant in Germany

DZL Researchers at Hannover Medical School (MHH) have performed the first living donor lung transplant in Germany.

Weiterlesen
5. August 2020
Assembly within the tumor center

Number of macrophages in tumor tissue enables prognosis of lung tumor progression.

Weiterlesen
15. April 2020
Helpers on the wrong path: Lymphocytes can force lung cancer

T-helper cells stimulate the building of lung cancer metastasis.

Weiterlesen
4. July 2019
Lung cancer screening: Women benefit significantly

Is computed tomography suitable for detecting lung cancer at a very early stage and thus still well treatable? Scientists at the German Cancer Research Center have investigated this with the LUSI study started in 2007.

Weiterlesen
21. March 2019
The Lung Microbiome – the latest ERS Monograph

Studying the lung microbiome requires a specialist approach to sampling, laboratory techniques and statistical analysis.

Weiterlesen
31. January 2019
Research: Molecular Diagnostics in 3,000 Patients with Lung Cancer: Tailor-Made Treatment

Meaningful data on genetic alterations in tumors provide the basis for successful targeted therapy.

Weiterlesen
28. February 2018
New findings on pleural effusion

Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall.

Weiterlesen
17. November 2017
How lung cancer triggers pulmonary hypertension

Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension – DZL scientists of…

Weiterlesen
29. May 2017
DZL Scientist Dr. Rajkumar Savai receives ATS Early Career Achievement Award

Dr. Rajkumar Savai from the Max Planck Institute for Heart and Lung Reseach (MPI) in Bad Nauheim (DZL site UGMLC) has recently received the Early Career Achievement Award from the American Thoracic Society (ATS) International Conference in Washington D.C. for the field of thoracic oncology. This award from the Assembly on Thoracic Oncology is given to an individual who has made most outstanding scientific contributions in clinical, translational, or laboratory‐based research early in his or her career.

Weiterlesen
22. May 2017
How cancer cells flood the lung

Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, member of the German Center for Lung Research (DZL), have discovered a novel mechanism that causes this to happen. Their study, published in ‘Nature Communications’, also shows that various active substances could potentially be used to treat this condition.

Weiterlesen
1. December 2016
DZL Investigator Dr. Rajkumar Savai receives Dr. Herbert Stolzenberg Award

His group identified signaling pathways that regulate crosstalk between tumor cells and macrophages...

Weiterlesen
16. November 2016
Immunotherapy with Pembrolizumab improves treatment of advanced lung cancer

Patients with advanced non-small-cell lung cancer may reckon with considerable improvements for their therapy. This is the promising result of a clinical study testing the antibody Pembrolizumab. Results of the study have been published recently in the renowned New England Journal of Medicine by a research team around DZL scientist and first author professor Martin Reck (LungenClinic Grosshansdorf, DZL site ARCN).

Weiterlesen
29. September 2016
Tracking lung cancer therapy and response in blood samples: successful proof-of-concept study

Scientists at the German Center for Lung Research (DZL), located at the German Center for Cancer Research (DKFZ), the National Center for Tumor Diseases and the Thoraxklinik in Heidelberg used liquid biopsies to detect mutations in circulating cell free DNA (cfDNA) in non-small-cell lung cancer (NSCLC) patients, which may provide a promising tool for early indication of therapy response and tumor progression in lung cancer patients.

Weiterlesen
15. February 2019
Everything at a Glance: New 3D Method Visualizes Nanoparticles in the Lungs

The new technology can be used to understand the therapeutic success of inhaled active substances.

Weiterlesen
30. September 2017
Erwin Schrödinger Prize awarded to DZL Scientist Fabian Theis and team

Theis and colleagues have shown how data from individual blood stem cells can be used to determine their fate...

Weiterlesen
9. December 2014
Prof. Roland Eils Receives HMLS Investigator Award

DZL PI Prof. Dr. Roland Eils receives the Heidelberg Molecular Life Sciences Investigator Award.

Weiterlesen
9. June 2014
DZL PI Receives Röntgenring

DZL Principal Investigator Jens Vogel-Claussen receives Wilhelm-Conrad-Röntgen-Ring

Weiterlesen
27. May 2014
DZL- Initiated ILD Registry "EXCITING" Goes Live

The new DZL- initiated registry for “Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases” (in short “EXCITING”) is now recruiting.

Weiterlesen
17. April 2014
DZL Researcher Receives Award from the European Congress of Radiology

TLRC Researcher, Dr. Mark Wielpütz,  received an award for the Best Scientific Paper Presentation 2014 at the European Congress of Radiology (ERC) Meeting.

Weiterlesen
28. June 2013
DZL Research Member Receives Young Investigator Award

DZL Research Member, Dr. Julius Renne receives Young Investigator Award at the 94th German Radiology Conference.

Weiterlesen
27. May 2013
DZL Researchers Pilot Novel Imaging Technology

DZL Researchers at the Thoraxklinik, University of Heidelberg generated the first human clinical images with a pioneering imaging technology.

Weiterlesen
17. July 2020
DZL-researcher elected as new EMBO Member

Ursula Klingmüller was recognised for her outstanding scientific achievements by being elected as a Member of the European Molecular Biology Organisation (EMBO).

Weiterlesen
26. April 2019
Dr. Astrid Weiß and Moritz Neubauer Honored with René Baumgart Award

Pulmonary Arterial Hypertension (PAH) is a progressive, fatal disease of the pulmonary vasculature. Affected patients have a poor prognosis, and treatment options are limited.

Weiterlesen
30. September 2017
Erwin Schrödinger Prize awarded to DZL Scientist Fabian Theis and team

Theis and colleagues have shown how data from individual blood stem cells can be used to determine their fate...

Weiterlesen
19. June 2017
Adolf-Windorfer prize awarded to DZL working group

Cystic Fibrosis: Junior Scientist Dr. Patricia Morán Losada...

Weiterlesen
29. May 2017
"SIC Rising Star of Research Award" for DZL Scientist Dr. Darcy Wagner

DZL Scientist Dr. Darcy E. Wagner, member of the Research Unit „Lung Repair and Regeneration“ at the DZL Site CPC-Munich and member of the Helmholtz Munich Postdoctoral Fellowship Program has been selected as a Science and Innovation Center (SIC) Rising Star of Research representing the Respiratory Cell and Molecular Biology (RCMB) Assembly for this year’s American Thoracic Society.

Weiterlesen
29. May 2017
DZL Scientist Dr. Rajkumar Savai receives ATS Early Career Achievement Award

Dr. Rajkumar Savai from the Max Planck Institute for Heart and Lung Reseach (MPI) in Bad Nauheim (DZL site UGMLC) has recently received the Early Career Achievement Award from the American Thoracic Society (ATS) International Conference in Washington D.C. for the field of thoracic oncology. This award from the Assembly on Thoracic Oncology is given to an individual who has made most outstanding scientific contributions in clinical, translational, or laboratory‐based research early in his or her career.

Weiterlesen
27. March 2017
DZL Scientist Prof. Dr. Marius Hoeper receives Oskar Medicine Award

...for his game-changing research in the area of Pulmonary Hypertension...

Weiterlesen
1. December 2016
DZL Investigator Dr. Rajkumar Savai receives Dr. Herbert Stolzenberg Award

His group identified signaling pathways that regulate crosstalk between tumor cells and macrophages...

Weiterlesen
9. December 2014
Prof. Roland Eils Receives HMLS Investigator Award

DZL PI Prof. Dr. Roland Eils receives the Heidelberg Molecular Life Sciences Investigator Award.

Weiterlesen
24. November 2014
DZL PI Dr. Mark Oliver Wielpütz Receives Christiane Herzog Research Award 2014

TLRC Researcher receives Christiane Herzog Research Award 2014.

Weiterlesen
19. November 2014
2014 Dickinson W. Richards Memorial Lecture given by DZL Speaker Werner Seeger

Prof. Dr. Werner Seeger gave the 2014 Dickinson W. Richards Memorial Lecture at the American Heart Association Meeting in Chicago.

Weiterlesen
14. October 2014
Prof. Magdalena Götz receives Ernst Schering Preis 2014

DZL Investigator receives Ernst-Schering Prize.

Weiterlesen
chevron-down